When clinical trials fail to address treatment gaps: The failure of niacin-laropiprant to reduce cardiovascular events

Robert S. Rosenson, Antonio M. Gotto

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish
Article number332
JournalCurrent Atherosclerosis Reports
Volume15
Issue number6
DOIs
StatePublished - Jun 2013

Keywords

  • Cardiovascular events
  • Clinical trials
  • Laropriprant
  • Niacin
  • Simvastatin

Cite this